glp 1 drugs and bipolar disorder GLP-1 receptor agonists show promise in treating substance use disorders Can GLP-1s Help People With

We still face several challenges: We need large-scale, randomized controlled trials specifically in RA, psoriasis, and PsA populations We need to understand the long-term effects of these drugs in autoimmune conditions We need to determine the optimal dosing and treatment duration for these new indications What This Means for You: A Personal Note As your rheumatologist, my primary concern is your well-being

fainting or feeling dizzy

Individuals with higher baseline GLP-1 deficiency or inflammatory profiles may show different response patterns

In addition, neuroinflammation causes immune cells (monocytes and lymphocytes in the blood, such as T cells and B cells) to infiltrate the central nervous system from the periphery across the BBB, accelerating neuroinflammation and neurodegeneration (49, 50)

Are willing to collaborate with you and other providers, and to provide clear lab and clinical follow-up